Incyte (INCY)
(Delayed Data from NSDQ)
$59.02 USD
-1.85 (-3.04%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $59.05 +0.03 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Earnings News For INCY
-
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
-
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
-
Incyte: Q1 Earnings Snapshot
-
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
-
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
-
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
-
Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report?
-
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
-
Incyte: Q4 Earnings Snapshot
-
Incyte (INCY) Lags Q4 Earnings and Revenue Estimates
-
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
-
Incyte (INCY) to Report Q4 Earnings: What's in the Cards?
-
Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?
-
Incyte (INCY) Beats on Q3 Earnings, Misses Revenue Estimates
-
Incyte (INCY) Surpasses Q3 Earnings Estimates
-
Incyte: Q3 Earnings Snapshot
-
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
-
Incyte (INCY) to Report Q3 Earnings: What's in the Cards?
-
Why Is Incyte (INCY) Down 0.7% Since Last Earnings Report?
-
Incyte (INCY) Beats on Q2 Earnings and Revenue Estimates
-
Incyte (INCY) Beats Q2 Earnings and Revenue Estimates
-
Incyte: Q2 Earnings Snapshot
-
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
-
Incyte (INCY) to Report Q2 Earnings: What's in the Cards?
-
Earnings Preview: Incyte (INCY) Q2 Earnings Expected to Decline